Showing results (131-140 of 334) with videos related to

Sort By:
Pageof 34
Cell Host & Microbe|July 20, 2011
Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challengeAlexei V Tumanov, Ekaterina P Koroleva, Xiaohuan Guo, et al.
Nature Communications|October 10, 2025
A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in miceWeian Cao, Junfan Chen, Yutong Fu, et al.
Cancer Letters|May 7, 2026
IL-12 Augments Adoptive Cell Therapy by Reshaping CD8+ T Dynamics and Broadening Antitumor ImmunityYue Huang, Xiangming Liu, Yiwei Chen, et al.
The Journal of Clinical Investigation|February 1, 2022
Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicityZhenhua Ren, Anli Zhang, Zhichen Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitisYonglian Sun, Xiaoqi Lin, Helen M Chen, et al.
Nature Reviews. Cancer|August 30, 2019
Phagocytosis checkpoints as new targets for cancer immunotherapyMingye Feng, Wen Jiang, Betty Y S Kim, et al.
European Journal of Immunology|September 16, 2004
A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell developmentRebecca H Lian, Robert K Chin, Hajnalka E Nemeth, et al.
Nature Communications|May 14, 2015
Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunityJ David Peske, Elizabeth D Thompson, Lelisa Gemta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
The critical role of LIGHT in promoting intestinal inflammation and Crohn's diseaseJing Wang, Robert A Anders, Yang Wang, et al.
Pageof 34